Volume 50 • Issue 1 • 2016

Introduction

Elizabeth Sepper

2016-01-01 Volume 50 • Issue 1 • 2016 • 001-009

Informed Consent as Compelled Professional Speech: Fictions, Facts, and Open Questions

Nadia N. Sawicki

2016-01-01 Volume 50 • Issue 1 • 2016 • 011-052

Clarifying Standards for Compelled Commercial Speech

Micah L. Berman

2016-01-01 Volume 50 • Issue 1 • 2016 • 053-087

Off-Label Drug Marketing, the First Amendment, and Federalism

David Orentlicher

2016-01-01 Volume 50 • Issue 1 • 2016 • 089-102

The First Amendment and the Politics of Reproductive Health Care

B. Jessie Hill

2016-01-01 Volume 50 • Issue 1 • 2016 • 103-122

A Natural Food Fight: The Battle Between the “Natural” Label and GMOs

Colleen Gray

2016-01-01 Volume 50 • Issue 1 • 2016 • 123-145

Shifting Automotive Landscapes: Privacy and the Right to Travel in the Era of Autonomous Motor Vehicles

Matthew Gillespie

2016-01-01 Volume 50 • Issue 1 • 2016 • 147-169

“Right to Try” Legislation and Its Implications for the FDA Drug Approval Process

Emily Hogan

2016-01-01 Volume 50 • Issue 1 • 2016 • 171-194

NAFTA Largely Responsible for the Obesity Epidemic in Mexico

Alana D. Siegel

2016-01-01 Volume 50 • Issue 1 • 2016 • 195-226

Table of Contents

2016-01-01 Volume 50 • Issue 1 • 2016

Editorial Board

2016-01-01 Volume 50 • Issue 1 • 2016

Mailing Statement

2016-01-01 Volume 50 • Issue 1 • 2016

Faculty List

2016-01-01 Volume 50 • Issue 1 • 2016

Mission Statement

2016-01-01 Volume 50 • Issue 1 • 2016

Title Page

2016-01-01 Volume 50 • Issue 1 • 2016